VEGFA and Alzheimer disease: Serum levels of VEGF and transforming growth factor-β1 (TGF-β1) are reduced in AD patients [140,141,142], with lower levels correlated with greater cognitive deficits [140], potentially suggestive of a contribution of angiogenic deficits to the evolution of the disease.